The mission of End Kids Cancer is to provide financial support for preclinical research and clinical trials that will cure neuroblastoma, with an emphasis on non-toxic treatments. This narrow focus on neuroblastoma is designed to increase the success of curing neuroblastoma. While the foundation’s focus is narrow, the benefits derived from advancements made in neuroblastoma will be broad. At the time of this writing, several other cancers will benefit from advancements made in neuroblastoma research. Some of the more commonly known are: breast cancer, lung cancer, brain cancer, liver cancer, skin cancer. The implications are significant. Our foundation’s secondary mission is to disseminate critical information we acquire while executing our primary mission.
There are children in communities all across the country, with a deadly form of childhood cancer, neuroblastoma, the most common cancer among infants. These children are fighting for their lives. Fewer than half will survive. These children are our focus.
A child anywhere in the country who is diagnosed with this deadliest form of cancer will, in all likelihood, be treated with protocols developed by doctors on our medical advisory board. This board evaluates and consults on cancer treatment research projects that our organization considers funding, cutting-edge research at the earliest stages.
Our placement of funds has already shown to be effective. FDA and NCI funding has followed our support of early phases cancer research of some of the most promising non-toxic treatments using immunotherapy.